The present invention relates to novel compounds which are useful in the treatment of diabetes and diabetes-related disorders. The invention also relates to pharmaceutical compositions comprising said compounds, intermediates useful in the preparation of said compounds, and methods of preparation.

 
Web www.patentalert.com

< Arylpiperazines having activity at the serotonin 1A receptor

< Methods for the treatment of back pain

> Fused heterotricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3

> Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
~ 00229